Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms

scientific article published on November 1, 1983

Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1152/AJPGI.1983.245.5.G601
P953full work available at URLhttps://www.physiology.org/doi/pdf/10.1152/ajpgi.1983.245.5.G601
P698PubMed publication ID6195926

P2093author name stringT. A. Miller
P433issue5 Pt 1
P407language of work or nameEnglishQ1860
P921main subjectphysiologyQ521
P304page(s)G601-23
P577publication date1983-11-01
P1433published inAmerican Journal of PhysiologyQ2160146
P1476titleProtective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms
P478volume245

Reverse relations

cites work (P2860)
Q6788091376th General Meeting of the Japanese Society of Gastroenterology. Tokyo, Japan, March 29-31, 1990. Abstracts
Q38974252A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury
Q41763552Acceleration of recovery of gastric epithelial integrity by 16,16-dimethyl prostaglandin E2.
Q36918403Acute toxicity and gastroprotective role of M. pruriens in ethanol-induced gastric mucosal injuries in rats
Q41048711Adaptive cytoprotection against deoxycholate-induced injury in human gastric cells in vitro: is there a role for endogenous prostaglandins?
Q74791962Adaptive cytoprotection induced by ethanol in human intestinal cells: role of prostaglandins and calcium homeostasis
Q40563667Adaptive cytoprotection induced by pretreatment with ethanol protects against gastric cell damage by NSAIDs
Q34475981Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology
Q44245363Alterations in rat intestinal mucin patterns following luminal infusion of acetylsalicylic acid and prostaglandin derivatives
Q73222629Anti-ulcer actions of the bark methanol extract of Voacanga africana in different experimental ulcer models in rats
Q38209865Anti-ulcer activity of essential oil constituents.
Q45017610Arachidonic acid and prostaglandin E2 activate small-conductance Cl- channels in the basolateral membrane of rabbit parietal cells
Q44596661Arachidonic acid does not protect against sodium taurocholate damage to rat gastric epithelial cell cultures
Q70348829Arachidonic acid stimulation of mucus production by rat gastric cultured cells
Q50893736Binding and biological actions of prostaglandin E2 and I2 in cells isolated from rabbit gastric mucosa.
Q46630704Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice
Q36009576Bombesin-induced gastroprotection
Q44901308Calcium channel blockers prevent stress-induced ulcers in rats.
Q38903808Cellular Energetical Actions of "Chemical" and "Surgical" Vagotomy in Gastrointestinal Mucosal Damage and Protection: Similarities, Differences and Significance for Brain-Gut Function
Q72642786Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins
Q35771324Cholecystokinin-induced gastroprotection: a review of current protective mechanisms
Q51587414Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Relation to diarrheagenic activity, leukocyte infiltration, and mucosal leukotrienes.
Q34527526Cigarette smoking reduces human gastric luminal prostaglandin E2
Q70275665Comparative mucosal protective properties of misoprostol, cimetidine, and sucralfate
Q26827673Current perspectives in NSAID-induced gastropathy
Q74435149Cyclooxygenase inhibition attenuates cholecystokinin-induced gastroprotection
Q37642691Cytoprotective and antioxidant effects of the methanol extract of Eremomastax speciosa in rats.
Q42484616Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase--two important gastroprotective enzymes
Q34529371Dietary essential fatty acids and the decline in peptic ulcer disease--a hypothesis
Q70043312Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa
Q93557405Effect of non-steroidal anti-inflammatory drugs on the human small intestine
Q72714303Effect of stress on the antioxidant enzymes and gastric ulceration
Q28195499Effect of various doses of palm vitamin E and tocopherol on aspirin-induced gastric lesions in rats
Q69785606Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man
Q28361095Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death
Q70275634Effects of absolute ethanol, misoprostol, cimetidine, and phosphate buffer on the morphology of rat gastric mucosae
Q41892467Effects of captopril on factors affecting gastric mucosal integrity in aspirin-induced gastric lesions in Sprague-Dawley rats
Q36415630Effects of extract F of red-rooted Salvia on mucosal lesions of gastric corpus and antrum induced by hemorrhagic shock-reperfusion in rats
Q69048005Effects of gastric distension and prostaglandin on acid ethanol-induced mucosal lesions in the rat
Q44922792Effects of granulocyte colony-stimulating factor on bacterial translocation due to burn wound sepsis
Q73222625Effects of methanol, cyclohexane and methylene chloride extracts of Bidens pilosa on various gastric ulcer models in rats
Q68479207Effects of milk, prostaglandin, and antacid on experimentally induced duodenitis in the rat. Use of myeloperoxidase as an index of inflammation
Q67979100Effects of secretin on content of PGE2 and 6-keto PGF1 alpha in gastric mucosa
Q35536139Endothelial cell growth regulation by PGE1 analog misoprostol and indomethacin
Q34069536Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.
Q43203862Essential fatty acids and peptic ulcer disease
Q68896723Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques
Q69467591Free radicals and lipid peroxidation in ethanol- or aspirin-induced gastric mucosal injury
Q37769451Gastric cytoprotection 30 years after its discovery by André Robert: a personal perspective
Q39682730Gastric cytoprotection: a critical appraisal of the concept, methodology, implications, mechanisms and future research prospects
Q53767646Gastric cytoprotective anti-ulcer effects of the leaf methanol extract of Ocimum suave (Lamiaceae) in rats.
Q70378474Gastric mucosal blood flow in misoprostol pretreated aspirin-induced ulceration
Q72408127Gastric mucosal high-energy phosphate metabolism. Influence of ethanol and PGE2
Q70275651Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study
Q46720932Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells
Q70123437Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate
Q72043962Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance
Q52573271HPLC-DAD identification of polyphenols from ethyl acetate extract of Amaranthus spinosus leaves and determination of their antioxidant and antinociceptive effects.
Q33317631Healing potential of Picrorhiza kurroa (Scrofulariaceae) rhizomes against indomethacin-induced gastric ulceration: a mechanistic exploration
Q38353541Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease
Q44563908Inability of cytoprotection to occur during a period of gastric ischemia
Q50508036Investigation of gastroprotective compounds at subcellular level in isolated gastric mucosal cells.
Q68835838Isolation, culture and characterization of human peritoneal mesothelial cells
Q70464121Isoproterenol prevents ethanol-induced microvascular stasis and deep histologic injury in rat gastric mucosa
Q36684818Isoproterenol-induced gastric mucosal protection from bile acid. Role of endogenous prostaglandins
Q46723164Low direct cytotoxicity and cytoprotective effects of nitric oxide releasing indomethacin
Q46679816Low direct cytotoxicity of nabumetone on gastric mucosal cells
Q35896167Mechanisms of Gastroprotective Effects of Ethanolic Leaf Extract of Jasminum sambac against HCl/Ethanol-Induced Gastric Mucosal Injury in Rats
Q43523926Mechanisms of protective activity of 16,16-dimethyl PGE2 and acetazolamide on gastric and duodenal lesions in rats
Q36072718Mechanistic aspects of gastric cytoprotection--a review
Q53896533Misoprostol preclinical pharmacology.
Q39540382Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease
Q22251417Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms
Q51585426Modulation of noradrenaline release in rat isolated stomach by prostanoids, but not by histaminergic mechanisms.
Q38974315Molecular Mechanism for Various Pharmacological Activities of NSAIDS
Q39764245Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective?
Q71833225Mucosal permeability after subclinical intestinal ischemia-reperfusion injury: An exploration of possible mechanisms
Q70240147Mucosal prostaglandin levels of the gastric stump
Q50906431N-acetyl-cysteine and prostaglandin. Comparable protection against experimental ethanol injury in the stomach independent of mucus thickness.
Q41331940NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus
Q40476391New insights into the mode of action of anti-inflammatory drugs
Q72863336Nicotine has no effect on rat gastric mucosal prostaglandin generation in vitro
Q40364679Nitrite in saliva increases gastric mucosal blood flow and mucus thickness.
Q36282905Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects
Q38627221Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management
Q40754162Nonsteroidal anti-inflammatory drugs. Differential use in older patients
Q42810069PGE2 protects isolated cells against injury through multiple mechanisms
Q69179540Preventive and curative effects of prostaglandins on stress ulcer in rats. Application of endoscopic observation
Q39253714Pro-ulcer effects of resveratrol in mice with indomethacin-induced gastric ulcers are reversed by L-arginine
Q74256030Prophylactic and healing properties of a new anti-ulcer compound from Enantia chlorantha in rats
Q36003997Prostaglandin formation by isolated gastric parietal and nonparietal cells of the rat.
Q52495591Prostaglandin protection of rat colonic mucosa from damage induced by ethanol.
Q42144808Prostaglandin protects against bile salt induced increases in proton permeation of duodenal brush border membrane
Q40511876Prostaglandin protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol
Q69960470Prostaglandin-induced gastric mucosal protection against stress injury. Absence of a relationship to tissue glutathione levels
Q37373318Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum
Q39832100Prostaglandins and histological changes in the gastric mucosa
Q41345878Prostaglandins in peptic ulcer disease. An overview of current status and future directions
Q40958153Prostaglandins protect human intestinal cells against ethanol injury by stabilizing microtubules: role of protein kinase C and enhanced calcium efflux
Q34192889Prostaglandins, thromboxanes and leukotrienes in clinical medicine
Q69995121Prostaglandins. A surgeon's perspective
Q54339880Protection of gastric mucosa against hypertonic sodium chloride by 16,16-dimethyl prostaglandin E2 or sodium thiosulfate in the rat: evidence for decreased mucosal penetration of damaging agent.
Q67534136Protective effect of 16,16-dimethyl prostaglandin E2 on isolated rat hepatocytes against complement-mediated immune attack
Q37658800Protective role of HSF1 and HSP70 against gastrointestinal diseases
Q35594597Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COX-1 and COX-2
Q64914477Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man.
Q71835005Reversion by histamine H2-receptor antagonists of plasma membrane alterations in ethanol-induced gastritis
Q84417386Role of capsaicin-sensitive primary afferent neurons and non-protein sulphydryl groups on gastroprotective effect of amifostine against ethanol-induced gastric damage in rats
Q71811783Role of dorsal motor nucleus of vagus in gastric function and mucosal damage induced by ethanol in rats
Q69358530Role of superoxide and hydroxyl radicals in rat gastric mucosal injury induced by ethanol
Q39571006Screening of Ficus religiosa leaves fractions for analgesic and anti-inflammatory activities.
Q35584950Smoking and the pathogenesis of gastroduodenal ulcer--recent mechanistic update
Q46528136Stimulation of electrogenic chloride secretion by prostaglandin E2 in guinea-pig isolated gastric mucosa
Q34391987Stimulation of glycoprotein and protein synthesis in isolated pig gastric mucosal cells by prostaglandins
Q42379006Store-operated Ca2+ Entry Facilitates the Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Gastric Cancer Cells
Q35755379Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?
Q46543423Suppression of ethanol-induced apoptotic DNA fragmentation by geranylgeranylacetone in cultured guinea pig gastric mucosal cells
Q26771996The antibacterial effect of fatty acids on Helicobacter pylori infection
Q67568274The degree of bacterial translocation is a determinant factor for mortality after burn injury and is improved by prostaglandin analogs
Q70372043The effects of 16,16-dimethyl prostaglandin E2 + aspirin on the canine gastric mucosal barrier
Q69185514The gastric mucosal barrier: tight junction structure in gastritis and ulcer biopsies
Q34081027The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone.
Q33814331The role of cyclooxygenases in inflammation, cancer, and development
Q42932529The role of erythropoietin in the protection of gastric mucosa from indometacin-induced gastric injury and its relationship with oxidant and antioxidant parameters in rats
Q37905581The use of vasopressin in the treatment of upper gastrointestinal haemorrhage
Q93513487Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins
Q35132201Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.
Q54061012Topical prostaglandin E2 protects isolated gastric mucosa against acidified taurocholate-, but not ethanol- or aspirin-induced injury.
Q44072323Transmucosal electrical resistance in rabbit isolated gastric mucosa during exposure to acid
Q93631220Ultrastructural effects of ulcerogens
Q70275639Ultrastructure of tight junctions in prostaglandin-exposed rat stomach
Q35195559Yu Ping Feng San, an ancient Chinese herbal decoction, regulates the expression of inducible nitric oxide synthase and cyclooxygenase-2 and the activity of intestinal alkaline phosphatase in cultures
Q69877626[Isolated human gastric mucosa cells--studies on physiologic and pharmacologic regulatory mechanisms]

Search more.